acetaminophen and codeine phosphate tablet
INDICATIONS AND USAGE Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. Limitations of Use Because of the risks of ADDICTION, ABUSE, AND MISUSE, with opioids, which can occur at any dosage or duration ( see WARNINGS ), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) Have not provided adequate analgesia, or are not expected to provide adequate analgesia, Have not been tolerated, or are not expected to be tolerated. Acetaminophen and codeine phosphate tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.
mallinckrodt, inc.
Related Pills
hydromorphone hydrochloride tablet
specgx llc
hydromorphone hydrochloride tablet
specgx llc
HYDROMORPHONE HYDROCHLORIDE Hydromorphone Hydrochloride 4 MG Oral Tablet
Mallinckrodt, Inc.
HYDROMORPHONE HYDROCHLORIDE Hydromorphone Hydrochloride 4 MG Oral Tablet
Mallinckrodt, Inc.
olmesartan medoxmil and hydrochlorothiazide tablet film coated
mylan pharmaceuticals inc.
pioglitazone tablet
mylan pharmaceuticals inc.
hydromorphone hydrochloride tablet
specgx llc
metoprolol tartrate tablet film coated
mylan institutional inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Each
ACETAMINOPHEN AND CODEINE PHOSPHATE Tablet USP 300 mg/15 mg tablet contains acetaminophen 300 mg and codeine phosphate 15 mg. It is available as a round, white to off-white tablet debossed with “2” on one side and an on the other side. Bottles of 100......................................... NDC 0406-0483-01 Each
ACETAMINOPHEN AND CODEINE PHOSPHATE Tablet USP 300 mg/30 mg tablet contains acetaminophen 300 mg and codeine phosphate 30 mg. It is available as a round, white to off-white tablet debossed with “3” on one side and an on the other side. Bottles of 20............................................ NDC 0406-0484-20 Bottles of 30............................................ NDC 0406-0484-03 Bottles of 50............................................ NDC 0406-0484-50 Bottles of 100......................................... NDC 0406-0484-01 Bottles of 1000....................................... NDC 0406-0484-10 Unit Dose (10 x 10)............................... NDC 0406-0484-62 Each
ACETAMINOPHEN AND CODEINE PHOSPHATE Tablet USP 300 mg/60 mg tablet contains acetaminophen 300 mg and codeine phosphate 60 mg. It is available as a round, white to off-white tablet debossed with “4” on one side and an on the other side. Bottles of 100......................................... NDC 0406-0485-01 Bottles of 500......................................... NDC 0406-0485-05 Store
ACETAMINOPHEN AND CODEINE PHOSPHATE tablets at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP. Store
ACETAMINOPHEN AND CODEINE PHOSPHATE tablets securely and dispose of properly ( see PRECAUTIONS, Information for Patients ). Mallinckrodt, the “M” brand mark, the Mallinckrodt Pharmaceuticals logo and are trademarks of a Mallinckrodt company. © 2023 Mallinckrodt. SpecGx LLC Webster Groves, MO 63119 USA Rev 11/2023 Mallinckrodt™ Pharmaceuticals An electronic copy of this medication guide can be obtained from www.mallinckrodt.com/Medguide/MG20A08.pdf or by calling 1-800-778-7898 for alternate delivery options. Boxed M Boxed M Boxed M Boxed M
More pills like ROUND M 4